Sign in
4

Changes in Ownership

BioXcel Therapeutics, Inc. Filed Acc 0001104659-18-017151

Options or other derivatives

  • Director acquired 37,209 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Laumas Sandeep · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2018-03-12 Grant or award : show line 1 in the form Stock Options +37,209 124,188 D
Loading xslF345X03/a4.xml…